Patient info Search Menu

Ibandronic Acid Teva 50 mg film-coated tablets ibandronic acid – patient leaflet, side effects, dosage

Contains active substance:

Patient leaflet - Ibandronic Acid Teva

1. What Ibandronic Acid Teva is and what it is used for

Ibandronic Acid Teva belongs to a group of medicines called bisphosphonates. It contains the active substance ibandronic acid. Ibandronic Acid Teva may reverse bone loss by stopping more loss of bone and increasing bone mass in most women who take it, even though they will not be able to see or feel a difference. Ibandronic Acid Teva may help lower the chances of breaking bones (fractures). This reduction in fractures was shown for the spine but not for the hip.

Ibandronic Acid Teva is prescribed to you to treat postmenopausal osteoporosis because you have an increased risk of fractures. Osteoporosis is a thinning and weakening of the bones, which is common in women after the menopause. At the menopause, a woman’s ovaries stop producing the female hormone, oestrogen, which helps to keep her skeleton healthy.

The earlier a woman reaches the menopause, the greater her risk of fractures in osteoporosis.

Other things that can increase the risk of fractures include:

  • not enough calcium and vitamin D in the diet,
  • smoking, or drinking too much alcohol,
  • not enough walking or other weight-bearing exercise,
  • a family history of osteoporosis.

A healthy lifestyle will also help you to get the most benefit from your treatment. This includes:

  • eating a balanced diet rich in calcium and vitamin D,
  • walking or any other weight-bearing exercise, - not smoking; and not drinking too much alcohol.

2. What you need to know before you take Ibandronic Acid Teva

Do not take Ibandronic Acid Teva

  • If you are allergic to ibandronic acid or any of the other ingredients of this medicine (listed in section 6).
  • If you have certain problems with your gullet/food pipe (oesophagus) such as narrowing or difficulty swallowing.
  • If you can’t stand or sit upright for at least one hour (60 minutes) at a time.
  • If you have, or had in the past low blood calcium. Please consult your doctor.

Warnings and precautions

A side effect called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported very rarely in the post-marketing setting in patients receiving Ibandronic Acid Teva for osteoporosis. ONJ can also occur after stopping treatment.

It is important to try and prevent ONJ developing as it is a painful condition that can be difficult to treat. In order to reduce the risk of developing osteonecrosis of the jaw, there are some precautions you should take.

Before receiving treatment, tell your doctor/nurse (health care professional) if:

  • you have any problems with your mouth or teeth such as poor dental health, gum disease or a planned tooth extraction.
  • you do not receive routine dental care or have not had a dental check up for a long time.
  • you are a smoker (as this may increase the risk of dental problems).
  • you have previously been treated with a bisphosphonate (used to treat or prevent bone disorders).
  • you are taking medicines called corticosteroids (such as prednisolone or dexamethasone).
  • you have cancer.

Your doctor may ask you to undergo a dental examination before starting treatment with Ibandronic Acid Teva.

While being treated, you should maintain good oral hygiene (including regular teeth brushing) and receive routine dental check-ups. If you wear dentures you should make sure these fit properly. If you are under dental treatment or will undergo dental surgery (e.g. tooth extractions), inform your doctor about your dental treatment and tell your dentist that you are being treated with Ibandronic Acid Teva.

Contact your doctor and dentist immediately if you experience any problems with your mouth or teeth such as loose teeth, pain or swelling, non-healing of sores or discharge, as these could be signs of osteonecrosis of the jaw.

Some people need to be especially careful while they’re taking Ibandronic Acid Teva. Talk to your doctor before taking Ibandronic Acid Teva:

  • If you have any disturbances of mineral metabolism (such as vitamin D deficiency).
  • If your kidneys are not functioning normally.
  • If you have any swallowing or digestive problems.

Irritation, inflammation or ulceration of the gullet/food pipe (oesophagus) often with symptoms of severe pain in the chest, severe pain after swallowing food and/or drink, severe nausea, or vomiting may occur, especially if you do not drink a full glass of water and/or if you lie down within an hour of taking Ibandronic Acid Teva. If you develop these symptoms, stop taking Ibandronic Acid Teva and tell your doctor straight away (see section 3).

Children and adolescents

Do not give Ibandronic Acid Teva to children or adolescents below 18 years.

Other medicines and Ibandronic Acid Teva

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Especially:

  • Supplements containing calcium, magnesium, iron or aluminium, as they could possibly

influence the effects of Ibandronic Acid Teva.

  • Acetylsalicylic acid and other non-steroidal anti-inflammatory medicines (NSAIDs) (including ibuprofen, diclofenac sodium and naproxen) may irritate the stomach and intestine. Ibandronic Acid Teva may also do so. So be especially careful if you take painkillers or anti-inflammatories while you’re taking Ibandronic Acid Teva.

After swallowing your monthly Ibandronic Acid Teva tablet, wait for 1 hour before taking any other medication, including indigestion tablets, calcium supplements, or vitamins.

Ibandronic Acid Teva with food and drink

Do not take Ibandronic Acid Teva with food. Ibandronic Acid Teva is less effective if it’s taken with food.

You can drink water but no other drinks.

After you have taken Ibandronic Acid Teva, please wait for 1 hour before you can have your first food and further drinks. (see 3. How to take Ibandronic Acid Teva).

Pregnancy and breast-feeding

Ibandronic Acid Teva is for use only by postmenopausal women and must not be taken by women who could still have a baby.

Do not take Ibandronic Acid Teva if you are pregnant or breast feeding. Ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

You can drive and use machines as it’s expected that Ibandronic Acid Teva has no or negligible effect on your ability to drive and use machines.

Ibandronic Acid Teva contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially ‘sodium-free’.

3. How to take Ibandronic Acid Teva

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The usual dose of Ibandronic Acid Teva is one tablet once a month.

Taking your monthly tablet

It’s important to follow these instructions carefully. They are designed to help your Ibandronic Acid Teva tablet reach your stomach quickly, so it’s less likely to cause irritation.

  • Take one Ibandronic Acid Teva 150 mg tablet once a month.
  • Choose one day of the month that will be easy to remember. You can choose either the same date (such as the 1st of each month) or the same day (such as the first Sunday of each month) to take your Ibandronic Acid Teva tablet. Choose the date that best fits your routine.
  • Take your Ibandronic Acid Teva tablet at least 6 hours after you last had anything to eat or drink except water.
  • Take your Ibandronic Acid Teva tablet
  • after you first get up for the day, and
  • before you have anything to eat or drink (on an empty stomach)
  • Swallow your tablet with a full glass of water (at least 180 ml).

Do not take your tablet with water with a high concentration of calcium, fruit juice or any other drinks. If there is a concern regarding potentially high levels of calcium in the tap water (hard water), it is advised to use bottled water with a low mineral content.

Swallow your tablet whole, — do not chew it, crush it or let it dissolve in your mouth.

For the next hour (60 minutes) after you’ve taken your tablet

  • do not lie down; if you do not stay upright (standing or sitting), some of the medicine could leak back into your oesophagus

do not eat anything

  • do not drink anything (except water if you need it)
  • do not take any other medicines
  • After you’ve waited for an hour, you can have your first food and drink of the day. Once you’ve eaten, it’s OK to lie down if you wish, and to take any other medication you need.

Continuing to take Ibandronic Acid Teva

It’s important to keep taking Ibandronic Acid Teva every month, as long as your doctor prescribes it for you. After 5 years of using Ibandronic Acid Teva, please consult with your doctor whether you should continue to take Ibandronic Acid Teva.

If you take more Ibandronic Acid Teva than you should

If you’ve taken more than one tablet by mistake, drink a full glass of milk and talk to your doctor straight away.

Do not make yourself vomit, and do not lie down — this could cause Ibandronic Acid Teva to irritate your oesophagus.

If you forget to take Ibandronic Acid Teva

  • If you forget to take your tablet on the morning of your chosen day, do not take a tablet later in the day.

Instead, consult your calendar and find out when your next scheduled dose is.

  • If you forgot to take your tablet on your chosen day and your next scheduled dose is only 1 to 7 days away...

Never take two Ibandronic Acid Teva tablets within the same week. You should wait until the next scheduled dose is due and take it as normal; then, continue taking one tablet once a month on the scheduled days you’ve marked on your calendar.

  • If you forgot to take your tablet on your chosen day and your next scheduled dose is more than 7 days away.

You should take one tablet the next morning after the day you remember; then, continue taking one tablet once a month on the scheduled days you’ve marked on your calendar.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Talk to a nurse or a doctor straight away if you notice any of the following serious side effects -you may need urgent medical treatment:

Uncommon (may affect up to 1 in 100 people):

  • severe pain in the chest, severe pain after swallowing food or drink, severe nausea, or vomiting, difficulty in swallowing. You may have a severe inflammation of your gullet/food pipe, possibly with sores or constriction of the gullet/food pipe

Rare (may affect up to 1 in 1000 people):

  • itching, swelling of your face, lips, tongue and throat, with difficulty breathing.
  • persistent eye pain and inflammation
  • new pain, weakness or discomfort in your thigh, hip or groin. You may have early signs of a possible unusual fracture of the thigh bone

Very rare (may affect up to 1 in 10,000 people):

  • pain or sore in your mouth or jaw. You may have early signs of severe jaw problems (necrosis [dead bone tissue] in the jaw bone)
  • Talk to your doctor if you have ear pain, discharge from the ear, and/or an ear infection. These could be signs of bone damage in the ear.
  • serious, potentially life-threatening allergic reaction
  • severe adverse skin reactions

Other possible side effects

Common (may affect up to 1 in 10 people):

  • headache
  • heartburn, discomfort in swallowing, stomach or tummy pain (may be due to an inflammation of the stomach), indigestion, nausea, having, diarrhoea (loose bowels) muscle cramps, stiffness of your joints and limbs
  • flu-like symptoms, including fever, shaking and shivering, feeling of discomfort, bone pain and aching muscles and joints. Talk to a nurse or doctor if any effects become troublesome or last more than a couple of days
  • rash

Uncommon (may affect up to 1 in 100 people):

  • dizziness
  • flatulence (farting, feeling bloated)
  • back pain
  • feeling tired and exhausted
  • asthma attacks

Rare (may affect up to 1 in 1000 people):

  • inflammation of the duodenum (first section of the bowel) causing stomach pain
  • hives

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. Y ou can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Ibandronic Acid Teva

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Ibandronic Acid Teva contains

  • The active substance is ibandronic acid.

Each film-coated tablet contains 150 mg ibandronic acid (as sodium monohydrate).

  • The other ingredients are:

tablet core: cellulose microcrystalline, povidone K-30, crospovidone (type A), silica colloidal anhydrous, stearic acid tablet coating: titanium dioxide (E 171), hypromellose, macrogol 400, polysorbate 80.

What Ibandronic Acid Teva looks like and contents of the pack

The Ibandronic Acid Teva film-coated tablets are white, biconvex, capsule-shaped, engraved “I150” on one side and plain on the other.

Ibandronic Acid Teva comes in blisters (PVC/Aclar/PVC - Aluminium) in cartons of 1 or 3 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder:

Teva B.V.

Swensweg 5

2031 GA Haarlem

The Netherlands

Manufacturer:

Teva Pharmaceutical Works Private Limited Company

Pallagi út 13,

4042 Debrecen

Hungary

Pharmachemie B.V.

Swensweg 5,

2031 GA Haarlem

The Netherlands

Teva Czech Industries s.r.o

Ostravska 29/305,

747 70 Opava-Komarov

Czech Republic

Teva Operations Poland Sp.z o.o ul. Mogilska 80

31-546 Krakow

Poland

For any information about this medicine, please contact the local representative of the Marketing

Authorisation Holder:

Belgie/Belgique/Belgien

Teva Pharma Belgium N.V./S.A./AG

Tél/Tel: +32 38207373

Etnrapua

TeBa OapMa EAfl

Ten: +359 24899585

Česká republika

Teva Pharmaceuticals CR, s.r.o.

Tel: +420 251007111

Danmark

Teva Denmark A/S

Tlf: +45 44985511

Deutschland

TEVA GmbH

Tel: +49 73140208

Eesti

UAB Teva Baltics Eesti filiaal

Tel: +372 6610801

EÀÀàôa

Specifar A.B.E.E.

Tql: +30 2118805000

España

Teva Pharma, S.L.U.

Tel: +34 913873280

France

Teva Santé

Tél: +33 155917800

Hrvatska

Pliva Hrvatska d.o.o.

Tel: +385 13720000

Ireland

Teva Pharmaceuticals Ireland

Tel: +44 2075407117

Ísland

Teva Pharma Iceland ehf.

Lietuva

UAB Teva Baltics

Tel: +370 52660203

Luxembourg/Luxemburg

Teva Pharma Belgium N.V./S.A./AG

Belgique/Belgien

Tél/Tel: +32 38207373

Magyarország

Teva Gyógyszergyár Zrt.

Tel: +36 12886400

Malta

Teva Pharmaceuticals Ireland

L-Irlanda

Tel: +44 2075407117

Nederland

Teva Nederland B.V.

Tel: +31 8000228400

Norge

Teva Norway AS

Tlf: +47 66775590

Österreich

ratiopharm Arzneimittel Vertriebs-GmbH

Tel: +43 1970070

Polska

Teva Pharmaceuticals Polska Sp. z o.o.

Tel: +48 223459300

Portugal

Teva Pharma - Produtos Farmaceuticos, Lda.

Tel: +351 214767550

Romania

Teva Pharmaceuticals S.R.L.

Tel: +40 212306524

Slovenija

Pliva Ljubljana d.o.o.

Tel: +386 15890390

Slovenská republika

TEVA Pharmaceuticals Slovakia s.r.o.

Simi: +354 5503300

Tel: +421 257267911

Italia

Teva Italia S.r.l.

Tel: +39 028917981

Kûnpoç

Specifar A.B.E.E.

EMôôa

Tql: +30 2118805000

Latvija

UAB Teva Baltics filiale Latvijä

Tel: +371 67323666

Suomi/Finland

Teva Finland Oy

Puh/Tel: +358 201805900

Sverige

Teva Sweden AB

Tel: +46 42121100

United Kingdom (Northern Ireland)

Teva Pharmaceuticals Ireland

Ireland

Tel: +44 2075407117

This leaflet was last approved in {MM/YYYY}.

Detailed information on this medicine is available on the European Medicines Agency web site:

http://www.ema.europa.eu/

53

About this document

Source: European Medicines Agency (EMA)

Našli jste chybu? Napište nám na info@nonstop-lekarna.cz.

The information on this site does not replace the advice of a doctor or pharmacist.